ResMed Inc. (RMD)

ResMed Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	5,146	4,685	4,223	3,578	3,197
Revenue Growth (YoY)	9.84%	10.95%	18.02%	11.93%	8.11%
Cost of Revenue	2,059	1,997	1,837	1,514	1,307
Gross Profit	3,087	2,688	2,386	2,064	1,889
Selling, General & Admin	991.02	917.14	874	737.51	670.39
Research & Development	331.28	307.53	287.64	253.58	225.28
Operating Expenses	1,400	1,304	1,234	1,062	971.88
Operating Income	1,687	1,384	1,152	1,002	917.55
Interest Expense	-0.59	-49.72	-51.13	-22.31	-23.63
Earnings From Equity Investments	3.64	-1.85	-7.27	-8.49	-11.21
Currency Exchange Gain (Loss)	-2.39	-0.14	-0.45	2.81	-0.75
Other Non Operating Income (Expenses)	1.83	0.66	-1.51	0.39	1.05
EBT Excluding Unusual Items	1,690	1,333	1,092	974.55	883.02
Merger & Restructuring Charges	-2.03	-64.23	-20.13	-1.86	-13.87
Gain (Loss) on Sale of Investments	-10.3	-4.05	9.92	-12.2	14.52
Pretax Income	1,678	1,265	1,102	960.48	883.66
Income Tax Expense	276.84	243.85	204.11	181.05	409.16
Net Income	1,401	1,021	897.56	779.44	474.51
Net Income to Common	1,401	1,021	897.56	779.44	474.51
Net Income Growth	37.20%	13.75%	15.15%	64.26%	-23.67%
Shares Outstanding (Basic)	147	147	147	146	145
Shares Outstanding (Diluted)	147	148	147	147	146
Shares Change (YoY)	-0.14%	0.06%	0.28%	0.40%	0.55%
EPS (Basic)	9.55	6.94	6.12	5.34	3.27
EPS (Diluted)	9.51	6.92	6.09	5.30	3.24
EPS Growth	37.43%	13.63%	14.91%	63.58%	-24.12%
Free Cash Flow	1,662	1,302	573.63	216.31	634.01
Free Cash Flow Per Share	11.28	8.82	3.89	1.47	4.33
Dividend Per Share	2.120	1.920	1.760	1.680	1.590
Dividend Growth	10.42%	9.09%	4.76%	5.66%	1.92%
Gross Margin	59.99%	57.38%	56.50%	57.68%	59.10%
Operating Margin	32.79%	29.54%	27.28%	28.01%	28.70%
Profit Margin	27.22%	21.79%	21.25%	21.78%	14.84%
Free Cash Flow Margin	32.29%	27.79%	13.58%	6.04%	19.83%
EBITDA	1,860	1,534	1,292	1,126	1,029
EBITDA Margin	36.15%	32.73%	30.60%	31.47%	32.19%
D&A For EBITDA	173	149.42	140.1	124.06	111.43
EBIT	1,687	1,384	1,152	1,002	917.55
EBIT Margin	32.79%	29.54%	27.28%	28.01%	28.70%
Effective Tax Rate	16.50%	19.28%	18.53%	18.85%	46.30%
Revenue as Reported	5,146	4,685	4,223	3,578	3,197

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q